Emergence of new manifestations during infliximab treatment in Behçet's syndrome.
Tukek NB, Esatoglu SN, Hatemi G, Calıskan EB, Ozyazgan Y, Ucar D, Ozguler Y, Seyahi E, Melikoglu M, Uygunoglu U, Siva A, Kutlubay Z, Hatemi İ, Celik AF, Ugurlu S, Fresko I, Yurdakul S, Yazici H, Hamuryudan V.
Tukek NB, et al. Among authors: caliskan eb.
Rheumatology (Oxford). 2022 Aug 30;61(9):3746-3753. doi: 10.1093/rheumatology/keab944.
Rheumatology (Oxford). 2022.
PMID: 34958357